Stable interaction between α5β1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1

Journal of Cell Biology

Volumn 170, Issue 6, 2005, Pages 993-1004

  Cascone, Ilaria ^a,b   Napione, Lucia ^a   Maniero, Fabrizio ^a   Serini, Guido ^a   Bussolino, Federico ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; ISOPROTEIN; LIGAND; PROTEIN; PROTEIN ANG 1; PROTEIN P85; TYROSINE KINASE RECEPTOR; TYROSINE KINASE RECEPTOR TIE2; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 5; 2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; CHROMONE DERIVATIVE; COLLAGEN TYPE 1; FIBRINOGEN; MORPHOLINE DERIVATIVE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL MOTILITY; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANGIOGENESIS; ANIMAL; CELL ADHESION; CELL LINE; CELL MOTION; CHICK EMBRYO; CHO CELL; CHORIOALLANTOIS; CRICETULUS; CULTURE TECHNIQUE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; HAMSTER; KINETICS; METABOLISM; SERODIAGNOSIS; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANGIOPOIETIN-1; ANIMALS; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL LINE; CELL MOVEMENT; CELL SURVIVAL; CHICK EMBRYO; CHO CELLS; CHORIOALLANTOIC MEMBRANE; CHROMONES; COLLAGEN TYPE I; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FIBRINOGEN; FIBRONECTINS; HUMANS; INTEGRIN ALPHA5BETA1; KINETICS; MORPHOLINES; NEOVASCULARIZATION, PHYSIOLOGIC; PRECIPITIN TESTS; RECEPTOR, TIE-2; UMBILICAL VEINS;

EID: 24944468632     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200507082     Document Type: Article

References (78)

1. Arai, F., A. Hirao, M. Ohmura, H. Sato, S. Matsuoka, K. Takubo, K. Ito, G.Y. Koh, and T. Suda. 2004. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 118:149-161.
2. Armstrong, P.B., and M.T. Armstrong. 2000. Intercellular invasion and the organizational stability of tissues: a role for fibronectin. Biochim. Biophys. Acta. 1470:9-20.
3. Arnaout, M.A., S.L. Goodman, and J.P. Xiong. 2002. Coming to grips with integrin binding to ligands. Curr. Opin. Cell Biol. 14:641-651.
4. Asahara, T., D. Chen, T. Takahashi, K. Fujikawa, M. Kearney, M. Magner, G.D. Yancopoulos, and J.M. Isner. 1998. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ. Res. 83:233-240.
5. Audero, E., I. Cascone, F. Maniero, L. Napione, M. Arese, L. Lanfrancone, and F. Bussolino. 2004. Adaptor ShcA protein binds tyrosine kinase Tie2 receptor and regulates migration and sprouting but not survival of endothelial cells. J. Biol. Chem. 279:13224-13233.
6. Baron, W., S.J. Shattil, and C. ffrench-Constant. 2002. The oligodendrocyte precursor mitogen PDGF stimulates proliferation by activation of alpha(v)beta3 integrins. EMBO J. 21:1957-66.
7. Bauer, J.S., J. Varner, C. Schreiner, L. Kornberg, R. Nicholas, and R.L. Juliano. 1993. Functional role of the cytoplasmic domain of the integrin alpha 5 subunit. J. Cell Biol. 122:209-221.
8. Beningo, K.A., M. Dembo, I. Kaverina, J.V. Small, and Y.L. Wang. 2001. Nascent focal adhesions are responsible for the generation of strong propulsive forces in migrating fibroblasts. J. Cell Biol. 153:881-888.
9. Borges, E., Y. Jan, and E. Ruoslahti. 2000. Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain. J. Biol. Chem. 275:39867-39873.
10. Brooks, P.C., R.A. Clark, and D.A. Cheresh. 1994. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science. 264:569-571.
11. Brooks, P.C., S. Stromblad, R. Klemke, D. Visscher, F.H. Sarkar, and D.A. Cheresh. 1995. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest. 96:1815-1822.
12. Burridge, K., and K. Wennerberg. 2004. Rho and Rac take center stage. Cell. 116:167-179.
13. Bussolino, F., M.F. Di Renzo, M. Ziche, E. Bocchietto, M. Olivero, L. Naldini, G. Gaudino, L. Tamagnone, A. Coffer, and P.M. Comoglio. 1992. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119:629-641.
14. Byzova, T.V., C.K. Goldman, N. Pampori, K.A. Thomas, A. Bett, S.J. Shattil, and E.F. Plow. 2000. A mechanism for modulation of cellular responses to VEGF: activation of integrins. Mol. Cell. 6:851-860.
15. Carlson, T., Y. Feng, P. Maisonpierre, M. Mrksich, and A. Morla. 2001. Direct cell adhesion to the angiopoietins mediated by integrins. J. Biol. Chem. 276:26516-26525.
16. Cascone, I., E. Audero, E. Giraudo, L. Napione, F. Maniero, M.R. Philips, J.G. Collard, G. Serini, and F. Bussolino. 2003a. Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1. Blood. 102:2482-2490.
17. Cascone, I., E. Giraudo, F. Caccavari, L. Napione, E. Bertotti, J.G. Collard, G. Serini, and F. Bussolino. 2003b. Temporal and spatial modulation of Rho GTPases during in vitro formation of capillary vascular network. Adherens junctions and myosin light chain as targets of Rac1 and RhoA. J. Biol. Chem. 278:50702-50713.
18. Chae, J.K., I. Kim, S.T. Lim, M.J. Chung, W.H. Kim, H.G. Kim, J.H. Ko, and G.Y. Koh. 2000. Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Arterioscler. Thromb. Vasc. Biol. 20:2573-2578.
19. Cho, S.Y., and R.L. Klemke. 2002. Purification of pseudopodia from polarized cells reveals redistribution and activation of Rac through assembly of a CAS/Crk scaffold. J. Cell Biol. 156:725-736.
20. Das, A., W. Fanslow, D. Cerretti, E. Warren, N. Talarico, and P. McGuire. 2003. Angiopoietin/Tek interactions regulate mmp-9 expression and retinal neovascularization. Lab. Invest. 83:1637-1645.
21. Davis, S., T.H. Aldrich, P.F. Jones, A. Acheson, D.L. Compton, V. Jain, T.E. Ryan, J. Bruno, C. Radziejewski, P.C. Maisonpierre, and G.D. Yancopoulos. 1996. Isolation of angiopoietin-1, a ligand for the Tie2 receptor, by secretion-trap expression cloning. Cell. 87:1161-1169.
22. Decker, L., and C. ffrench-Constant. 2004. Lipid rafts and integrin activation regulate oligodendrocyte survival. J. Neurosci. 24:3816-3825.
23. Dike, L.E., C.S. Chen, M. Mrksich, J. Tien, G.M. Whitesides, and D.E. Ingber. 1999. Geometric control of switching between growth, apoptosis, and differentiation during angiogenesis using micropatterned substrates. In Vitro Cell. Dev. Biol. Anim. 35:441-448.
24. Drake, C.J., D.A. Cheresh, and C.D. Little. 1995. An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization. J. Cell Sci. 108:2655-2661.
25. Dumont, D.J., G. Gradwohl, G.H. Fong, M.C. Puri, M. Gertsenstein, A. Auerbach, and M.L. Breitman. 1994. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8:1897-1909.
26. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:27-31.
27. Francis, S.E., K.L. Goh, K.M. Hodivala-Dilke, B.L. Bader, M. Stark, D. Davidson, and R.O. Hynes. 2002. Central role of alpha(5)beta(1) integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler. Thromb. Vasc. Biol. 22:927-933.
28. George, E.L., E.N. Georges-Labouesse, R.S. Patel-King, H. Rayburn, and R.O. Hynes. 1993. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development. 119:1079-1091.
29. Giancotti, F.G., and E. Ruoslahti. 1999. Integrin signaling. Science. 285:1028-1032.
30. Goel, H.L., M. Fornaro, L. Moro, N. Teider, J.S. Rhim, M. King, and L.R. Languino. 2004. Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by beta1 integrins. J. Cell Biol. 166:407-418.
31. Guilherme, A., K. Torres, and M.P. Czech. 1998. Cross-talk between insulin receptor and integrin alpha5 beta1 signaling pathways. J. Biol. Chem. 273:22899-22903.
32. Hammes, H.P., M. Brownlee, A. Jonczyk, A. Sutter, and K.T. Preissner. 1996. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat. Med. 2:529-533.
33. Hangai, M., Y.S. Moon, N. Kitaya, C.K. Chan, D.Y. Wu, K.G. Peters, S.J. Ryan, and D.R. Hinton. 2001. Systematically expressed soluble Tie2 inhibits intraocular neovascularization. Hum. Gen. Ther. 12:1311-1321.
34. Hawighorst, T., M. Skobe, M. Streit, Y.K. Hong, P. Velasco, L.F. Brown, L. Riccardi, B. Lange-Asschenfeldt, and M. Detmar. 2002. Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth. Am. J. Pathol. 160:1381-1392.
35. Hodivala-Dilke, K.M., A.R. Reynolds, and L.E. Reynolds. 2003. Integrins in angiogenesis: multitalented molecules in a balancing act. Cell Tissue Res. 314:131-144.
36. Hood, J.D., and D.A. Cheresh. 2002. Role of integrins in cell invasion and migration. Nat. Rev. Cancer. 2:91-100.
37. Hunter, T. 2000. Signaling - 2000 and beyond. Cell. 100:113-127.
38. Hynes, R.O. 2002. Integrins: bidirectional, allosteric signaling machines. Cell. 110:673-687.
39. Jones, N., K. Iljin, D.J. Dumont, and K. Alitalo. 2001. Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat. Rev. Mol. Cell Biol. 2:257-267.
40. Kalluri, R. 2003. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer. 3:422-433.
41. Kim, I., H.G. Kim, J.N. So, J.H. Kim, H.J. Kwak, and G.Y. Koh. 2000a. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Circ. Res. 86:24-29.
42. Kim, S., K. Bell, S.A. Mousa, and J.A. Varner. 2000b. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am. J. Pathol. 156:1345-1362.
43. Koblizek, T.I., C. Weiss, G.D. Yancopoulos, U. Deutsch, and W. Risau. 1998. Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr. Biol. 8:529-532.
44. Kontos, C.D., T.P. Stauffer, W.P. Yang, J.D. York, L. Huang, M.A. Blanar, T. Meyer, and K.G. Peters. 1998. Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol. Cell. Biol. 18:4131-4140.
45. Lee, J.W., and R.L. Juliano. 2002. The alpha5beta1 integrin selectively enhances epidermal growth factor signaling to the phosphatidylinositol-3-kinase/ Akt pathway in intestinal epithelial cells. Biochim. Biophys. Acta. 1542:23-31.
46. Lemieux, C., R. Maliba, J. Favier, J.F. Theoret, Y. Merhi, and M.G. Sirois. 2005. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood. 105:1523-1530.
47. Machein, M., A. Knelda, R. Knoth, S. Wagner, E. Neuschl, and K. Plate. 2004. Angiopoietin-1 promotes angiogenesis in a rat glioma model. Am. J. Pathol. 165:1557-1571.
48. Max, R., R.R. Gerritsen, P.T. Nooijen, S.L. Goodman, A. Sutter, U. Keilholz, D.J. Ruiter, and R.M. De Waal. 1997. Immunohistochemical analysis of integrin alpha vbeta3 expression on tumor-associated vessels of human carcinomas. Int. J. Cancer. 71:320-324.
49. Metheny-Barlow, L.J., and L.Y. Li. 2003. The enigmatic role of angiopoietin-1 in tumor angiogenesis. Cell Res. 13:309-317.
50. Miao, H., S. Li, Y. Hu, S. Yuan, Y. Zhao, B.P.C. Chen, W. Puzon-McLaughlin, T. Takehiko, J.Y.-J. Shyy, Y. Takada, et al. 2002. Differential regulation of Rho GTPases by beta1 and beta3 integrins: the role of an extracellular domain of integrin in intracellular signaling. J. Cell Sci. 115:2199-2206.
51. Miyamoto, S., H. Teramoto, J.S. Gutkind, and K.M. Yamada. 1996. Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors. J. Cell Biol. 135:1633-1642.
52. Moro, L., M. Venturino, C. Bozzo, L. Silengo, F. Altruda, L. Beguinot, G. Tarone, and P. Defilippi. 1998. Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion-dependent cell survival. EMBO J. 17:6622-6632.
53. Papapetropoulos, A., G. Garcia-Cardena, T.J. Dengler, P.C. Maisonpierre, G.D. Yancopoulos, and W.C. Sessa. 1999. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab. Invest. 79:213-223.
54. Rousseau, S., F. Houle, and J. Huot. 2002. Integrating the VEGF signals leading to actin-based motility in vascular endothelial cells. Trends Cardiovasc. Med. 10:321-327.
55. Sato, T.N., Y. Tozawa, U. Deutsch, K. Wolburg-Buchholz, Y. Fujiwara, M. Gendron-Maguire, T. Gridley, H. Wolburg, W. Risau, and Y. Qin. 1995. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 376:70-74.
56. Schlaepfer, D.D., and S.K. Mitra. 2004. Multiple connections link FAK to cell motility and invasion. Curr. Opin. Genet. Dev. 14:92-101.
57. Schneller, M., K. Vuori, and E. Ruoslahti. 1997. Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF. EMBO J. 16:5600-5607.
58. Senger, D.R., K.P. Claffey, J.E. Benes, C.A. Perruzzi, A.P. Sergiou, and M. Detmar. 1997. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. Proc. Natl. Acad. Sci. USA. 94:13612-13617.
59. Serini, G., D. Ambrosi, E. Giraudo, A. Gamba, L. Preziosi, and F. Bussolino. 2003a. Modeling the early stages of vascular network assembly. EMBO J. 22:1771-1779.
60. Serini, G., D. Valdembri, S. Zanivan, G. Morterra, C. Burkhardt, F. Caccavari, L. Zammataro, L. Primo, L. Tamagnone, M. Logan, et al. 2003b. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature. 424:391-397.
61. Shim, W.S., M. Teh, A. Bapna, I. Kim, G.Y. Koh, P.O.P. Mack, and R. Ge. 2002. Angiopoietin-1 promotes tumor angiogenesis and tumor vessel plasticity of human cervical cancer in mice. Exp. Cell Res. 279:299-309.
62. Shyu, K., O. Manor, M. Magner, G.D. Yancopoulos, and J.M. Isner. 1998. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation. 98:2081-2087.
63. Sieg, D.J., C.R. Hauck, D. Ilic, C.K. Klingbeil, E. Schaefer, C.H. Damsky, and D.D. Schlaepfer. 2000. FAK integrates growth-factor and integrin signals to promote cell migration. Nat. Cell Biol. 2:249-256.
64. Soldi, R., S. Mitola, M. Strasly, P. Defilippi, G. Tarone, and F. Bussolino. 1999. Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J. 18:882-892.
65. Stoeltzing, O., S.A. Ahmad, W. Liu, M.F. McCarty, J.S. Wey, A.A. Parikh, F. Fan, N. Reinmuth, M. Kawaguchi, C.D. Bucana, and L.M. Ellis. 2003. Angiopoietin-1 inhibits vascular permeability, angiogenesis and growth of hepatic colon cancer tumors. Cancer Res. 63:3370-3377.
66. Stupack, D.G., and D.A. Cheresh. 2002. ECM remodeling regulates angiogenesis: endothelial integrins look for new ligands. Sci. STKE. 119:1-6.
67. Suri, C., P.F. Jones, S. Patan, S. Bartunkova, P.C. Maisonpierre, S. Davis, T.N. Sato, and G.D. Yancopoulos. 1996. Requisite role of angiopoietin-1, a ligand for the Tie2 receptor, during embryonic angiogenesis. Cell. 87:1171-1180.
68. Suri, C., J. McClain, G. Thurston, D.M. McDonald, H. Zhou, E.H. Oldmixon, T.N. Sato, and G.D. Yancopoulos. 1998. Increased vascularization in mice overexpressing angiopoietin-1. Science. 282:468-471.
69. Taverna, D., and R.O. Hynes. 2001. Reduced blood vessel formation and tumor growth in alpha5-integrin-negative teratocarcinomas and embryoid bodies. Cancer Res. 61:5255-5261.
70. Thurston, G., Q. Wang, F. Baffert, J. Rudge, N. Papadopoulos, D. Jean-Guillaume, S. Wlegand, G.D. Yancopoulos, and D.M. McDonald. 2005. Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period. Development. 132:3317-3326.
71. Uemura, A., M. Ogawa, M. Hirashima, T. Fujiwara, S. Koyama, H. Takagi, Y. Honda, S.T. Wiegand, G.D. Yancopoulos, and S. Nishikawa. 2002. Recombinant angiopoietin-1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J. Clin. Invest. 110: 1619-1628.
72. Valdembri, D., G. Serini, A. Vacca, D. Ribatti, and F. Bussolino. 2002. In vivo activation of JAK2/STAT-3 pathway during angiogenesis induced by GM-CSF. FASEB J. 16:225-227.
73. Wang, F., P. Herzmark, O.D. Weiner, S. Srinivasan, G. Servant, and H.R. Bourne. 2002. Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils. Nat. Cell Biol. 4:513-518.
74. Woodard, A.S., G. Garcia-Cardena, M. Leong, J.A. Madri, W.C. Sessa, and L.R. Languino. 1998. The synergistic activity of alphavbeta3 integrin and PDGF receptor increases cell migration. J. Cell Sci. 111:469-478.
75. Xu, Y., and Q. Yu. 2001. Angiopoietin-1, unlike angiopoietin-2, is incorporated into the extracellular matrix via its linker peptide region. J. Biol. Chem. 37:34990-34998.
76. Yancopoulos, G.D., S. Davis, N.W. Gale, J.S. Rudge, S.J. Wiegand, and J. Holash. 2000. Vascular-specific growth factors and blood vessel formation. Nature. 407:242-248.
77. Yang, J.T., H. Rayburn, and R.O. Hynes. 1993. Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development. 119:1093-1105.
78. Zhu, W.H., A. MacIntyre, and R.F. Nicosia. 2002. Regulation of angiogenesis by vascular endothelial growth factor and angiopoietin-1 in the rat aorta model: distinct temporal patterns of intracellular signaling correlate with induction of angiogenic sprouting. Am. J. Pathol. 161:823-830.